Skip to Content

Notice

Notice of Closed Meeting

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Pursuant to section 10(d) of the Federal Advisory Committee Act, as Start Printed Page 9524amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Chief Operating Officer, CDC, pursuant to Public Law 92-463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—GH19-003, Advancing Infectious Disease Detection and Response in Senegal; GH19-006, Advancing Infectious Disease Detection and Response in Indonesia; GH19-008, Advancing Infectious Disease Detection and Response in Uganda; GH19-009, Advancing Infectious Disease Detection and Response in Vietnam; GH19-010, Advancing Disease Detection and Response in Nigeria; and GH19-015, Strengthening National Capacity for Malaria Operations Research in Malawi.

Date: April 24, 2019.

Time: 9:00 a.m.-2:00 p.m., EDT.

Place: Teleconference.

Agenda: To review and evaluate grant applications.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Hylan Shoob, Ph.D., Scientific Review Officer, Center for Global Health, CDC, 1600 Clifton Drive, Atlanta, GA 30329-4027,(404) 639-4796; HShoob@cdc.gov.

The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Start Signature

Sherri Berger,

Chief Operating Officer, Centers for Disease Control and Prevention.

End Signature End Further Info End Preamble

[FR Doc. 2019-04848 Filed 3-14-19; 8:45 am]

BILLING CODE 4163-18-P